Potential therapeutic uses of BDNF in neurological and psychiatric disorders (original) (raw)

• Levi-Montalcini, R. & Hamburger, V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool. 116, 321–361 (1951).
  Article CAS PubMed Google Scholar
• Johnson, E. M. Jr & Tuszynski, M. H. in CNS Regeneration (eds. Kordower, J. H. & Tuszynski, M. H.) 95–144 (Academic Press, San Diego, 2008).
  Book Google Scholar
• Barde, Y. A., Edgar, D. & Thoenen, H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1, 549–553 (1982). This landmark article presented the discovery of BDNF.
  Article CAS PubMed PubMed Central Google Scholar
• Mowla, S. J. et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 276, 12660–12666 (2001).
  Article CAS PubMed Google Scholar
• Mowla, S. J. et al. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J. Neurosci. 19, 2069–2080 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, R., Kermani, P., Teng, K. K. & Hempstead, B. L. Regulation of cell survival by secreted proneurotrophins. Science 294, 1945–1948 (2001).
  Article CAS PubMed Google Scholar
• Nikoletopoulou, V. et al. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 467, 59–63 (2010).
  Article CAS PubMed Google Scholar
• Rauskolb, S. et al. Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J. Neurosci. 30, 1739–1749 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Matsumoto, T. et al. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nature Neurosci. 11, 131–133 (2008).
  Article CAS PubMed Google Scholar
• Soppet, D. et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65, 895–903 (1991).
  Article CAS PubMed Google Scholar
• Carter, B. D. et al. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 272, 542–545 (1996).
  Article CAS PubMed Google Scholar
• Tanaka, J. et al. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science 319, 1683–1687 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Horch, H. W. & Katz, L. C. BDNF release from single cells elicits local dendritic growth in nearby neurons. Nature Neurosci. 5, 1177–1184 (2002).
  Article CAS PubMed Google Scholar
• Figurov, A., Pozzo-Miller, L. D., Olafsson, P., Wang, T. & Lu, B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381, 706–709 (1996).
  Article CAS PubMed Google Scholar
• Kang, H. & Schuman, E. M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267, 1658–1662 (1995).
  Article CAS PubMed Google Scholar
• Yamada, K., Mizuno, M. & Nabeshima, T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 70, 735–744 (2002).
  Article CAS PubMed Google Scholar
• Egan, M. F. et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269 (2003). An important study that described a Val66Met BDNF gene polymorphism that is associated with memory deficits and altered hippocampal function.
  Article CAS PubMed Google Scholar
• Cathomas, F., Vogler, C., Euler-Sigmund, J. C., de Quervain, D. J. & Papassotiropoulos, A. Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory. Int. J. Neuropsychopharmacol. 13, 975–980 (2010).
  Article CAS PubMed Google Scholar
• Xu, B. et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neurosci. 6, 736–742 (2003).
  Article CAS PubMed Google Scholar
• Cao, L. et al. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nature Med. 15, 447–454 (2009). This study used gene delivery techniques to control BDNF expression in an animal model of obesity.
  Article CAS PubMed Google Scholar
• Nagahara, A. H. et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nature Med. 15, 331–337 (2009). This article demonstrated the therapeutic effects of BDNF in six animal models of Alzheimer's disease, ranging from mouse models to non-human primate models.
  Article CAS PubMed Google Scholar
• Smith, D. E., Roberts, J., Gage, F. H. & Tuszynski, M. H. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc. Natl Acad. Sci. USA 96, 10893–10898 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kordower, J. H. et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767–773 (2000).
  Article CAS PubMed Google Scholar
• Tuszynski, M. H. et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nature Med. 11, 551–555 (2005). A report on the first clinical trial of growth factor gene therapy in a human neurodegenerative disorder: Alzheimer's disease.
  Article CAS PubMed Google Scholar
• Bradley, W. G. A phase I/II study of recombinant brain-derived neurotrophic factor in patients with ALS. Ann. Neurol. 38, 971 (1995).
  Article Google Scholar
• Apfel, S. C. et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 51, 695–702 (1998).
  Article CAS PubMed Google Scholar
• Kordower, J. H. et al. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann. Neurol. 46, 419–424 (1999).
  Article CAS PubMed Google Scholar
• Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82, 239–259 (1991).
  Article CAS Google Scholar
• Kordower, J. H. et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49, 202–213 (2001).
  Article CAS PubMed Google Scholar
• Masliah, E. et al. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 174, 67–72 (1994).
  Article CAS PubMed Google Scholar
• Yan, Q. et al. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 78, 431–448 (1997).
  Article CAS PubMed Google Scholar
• Altar, C. A. et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856–860 (1997).
  Article CAS PubMed Google Scholar
• Kovalchuk, Y., Hanse, E., Kafitz, K. W. & Konnerth, A. Postsynaptic induction of BDNF-mediated long-term potentiation. Science 295, 1729–1734 (2002).
  Article CAS PubMed Google Scholar
• Connor, B. et al. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 49, 71–81 (1997).
  Article CAS PubMed Google Scholar
• Hock, C., Heese, K., Hulette, C., Rosenberg, C. & Otten, U. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch. Neurol. 57, 846–851 (2000).
  Article CAS PubMed Google Scholar
• Narisawa-Saito, M., Wakabayashi, K., Tsuji, S., Takahashi, H. & Nawa, H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 7, 2925–2928 (1996).
  Article CAS PubMed Google Scholar
• Mucke, L. et al. High-level neuronal expression of Aβ1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Burbach, G. J. et al. Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J. Neurosci. 24, 2421–2430 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Blurton-Jones, M. et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl Acad. Sci. USA 106, 13594–13599 (2009). An important paper indicating that BDNF that is secreted by transplanted embryonic stem cells exerts therapeutic effects in a mouse model of Alzheimer's disease.
  Article CAS PubMed PubMed Central Google Scholar
• Olanow, C. W. & Tatton, W. G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123–144 (1999).
  Article CAS PubMed Google Scholar
• Hyman, C. et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230–232 (1991).
  Article CAS PubMed Google Scholar
• Mogi, M. et al. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci. Lett. 270, 45–48 (1999).
  Article CAS PubMed Google Scholar
• Parain, K. et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport 10, 557–561 (1999).
  Article CAS PubMed Google Scholar
• Levivier, M., Przedborski, S., Bencsics, C. & Kang, U. J. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15, 7810–7820 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Frim, D. M. et al. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl Acad. Sci. USA 91, 5104–5108 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Tsukahara, T., Takeda, M., Shimohama, S., Ohara, O. & Hashimoto, N. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced parkinsonism in monkeys. Neurosurgery 37, 733–741 (1995).
  Article CAS PubMed Google Scholar
• Orr, H. T. & Zoghbi, H. Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575–621 (2007).
  Article CAS PubMed Google Scholar
• Walker, F. O. Huntington's disease. Lancet 369, 218–228 (2007).
  Article CAS PubMed Google Scholar
• Zuccato, C. et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493–498 (2001).
  Article CAS PubMed Google Scholar
• Baquet, Z. C., Gorski, J. A. & Jones, K. R. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J. Neurosci. 24, 4250–4258 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Gauthier, L. R. et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127–138 (2004).
  Article CAS PubMed Google Scholar
• Strand, A. D. et al. Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J. Neurosci. 27, 11758–11768 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zala, D. et al. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol. Dis. 20, 785–798 (2005).
  Article CAS PubMed Google Scholar
• Canals, J. M. et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci. 24, 7727–7739 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Simmons, D. A. et al. Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc. Natl Acad. Sci. USA 106, 4906–4911 (2009). This article reported that ampakines increase BDNF expression in the brain and reduce deficits in a transgenic mouse model of Huntington's disease.
  Article PubMed PubMed Central Google Scholar
• Kells, A. P., Henry, R. A. & Connor, B. AAV–BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Gene Ther. 15, 966–977 (2008).
  Article CAS PubMed Google Scholar
• Kaplan, D. R. & Miller, F. D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381–391 (2000).
  Article CAS PubMed Google Scholar
• Wijesekera, L. C. & Leigh, P. N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 4, 3 (2009).
  Article PubMed PubMed Central Google Scholar
• Tuszynski, M. H., Mafong, E. & Meyer, S. BDNF and NT-4/5 prevent injury-induced motor neuron degeneration in the adult central nervous system. Neuroscience 71, 761–771 (1996).
  Article CAS PubMed Google Scholar
• Giehl, K. M. & Tetzlaff, W. BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo. Eur. J. Neurosci. 8, 1167–1175 (1996).
  Article CAS PubMed Google Scholar
• Mitsumoto, H. et al. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265, 1107–1110 (1994).
  Article CAS PubMed Google Scholar
• [No authors listed.] A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF study group (Phase III). Neurology 52, 1427–1433 (1999). This was a major report on a Phase III multicentre trial of BDNF protein administration in a neurodegenerative disease: ALS.
• Beck, M. et al. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 6, 100–103 (2005).
  Article CAS PubMed Google Scholar
• Ochs, G. et al. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 201–206 (2000).
  Article CAS PubMed Google Scholar
• Ankeny, D. P. et al. Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury. Exp. Neurol. 170, 85–100 (2001).
  Article CAS PubMed Google Scholar
• Pardridge, W. M., Wu, D. & Sakane, T. Combined use of carboxyl-directed protein pegylation and vector-mediated blood–brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharm. Res. 15, 576–582 (1998).
  Article CAS PubMed Google Scholar
• Doyle, K. P., Simon, R. P. & Stenzel-Poore, M. P. Mechanisms of ischemic brain damage. Neuropharmacology 55, 310–318 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ferrer, I. et al. Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol. 101, 229–238 (2001).
  CAS PubMed Google Scholar
• Muller, H. D. et al. Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain. Stroke 39, 1012–1021 (2008).
  Article CAS PubMed Google Scholar
• Larsson, E., Nanobashvili, A., Kokaia, Z. & Lindvall, O. Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 19, 1220–1228 (1999).
  Article CAS PubMed Google Scholar
• Huang, E. J. & Reichardt, L. F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677–736 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Gordon, T., Sulaiman, O. & Boyd, J. G. Experimental strategies to promote functional recovery after peripheral nerve injuries. J. Peripher. Nerv. Syst. 8, 236–250 (2003).
  Article PubMed Google Scholar
• Tobias, C. A. et al. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. 184, 97–113 (2003).
  Article CAS PubMed Google Scholar
• Blesch, A. & Tuszynski, M. H. Transient growth factor delivery sustains regenerated axons after spinal cord injury. J. Neurosci. 27, 10535–10545 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, P., Blesch, A. & Tuszynski, M. H. Neurotrophism without neurotropism: BDNF promotes survival but not growth of lesioned corticospinal neurons. J. Comp. Neurol. 436, 456–470 (2001).
  Article CAS PubMed Google Scholar
• Stokols, S. & Tuszynski, M. H. Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury. Biomaterials 27, 443–451 (2006).
  Article CAS PubMed Google Scholar
• Blesch, A. & Tuszynski, M. H. Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci. 32, 41–47 (2009).
  Article CAS PubMed Google Scholar
• Alto, L. T. et al. Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury. Nature Neurosci. 12, 1106–1113 (2009).
  Article CAS PubMed Google Scholar
• Hollis, E. R., Jamshidi, P., Low, K., Blesch, A. & Tuszynski, M. H. Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation. Proc. Natl Acad. Sci. USA 106, 7215–7220 (2009).
  Article PubMed PubMed Central Google Scholar
• Plunet, W. T. et al. Dietary restriction started after spinal cord injury improves functional recovery. Exp. Neurol. 213, 28–35 (2008).
  Article PubMed Google Scholar
• Ying, Z. et al. BDNF-exercise interactions in the recovery of symmetrical stepping after a cervical hemisection in rats. Neuroscience 155, 1070–1078 (2008).
  Article CAS PubMed Google Scholar
• Schumacher, J. et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58, 307–314 (2005).
  Article CAS PubMed Google Scholar
• Post, R. M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res. 41, 979–990 (2007).
  Article PubMed Google Scholar
• Kato, M. & Serretti, A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry 15, 473–500 (2010).
  Article CAS PubMed Google Scholar
• Campbell, S., Marriott, M., Nahmias, C. & MacQueen, G. M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 161, 598–607 (2004).
  Article PubMed Google Scholar
• Dwivedi, Y. et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60, 804–815 (2003).
  Article CAS PubMed Google Scholar
• Brunoni, A. R., Lopes, M. & Fregni, F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11, 1169–1180 (2008).
  Article CAS PubMed Google Scholar
• Vermetten, E., Vythilingam, M., Southwick, S. M., Charney, D. S. & Bremner, J. D. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 54, 693–702 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Sen, S., Duman, R. & Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 64, 527–532 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Shimizu, E. et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 54, 70–75 (2003).
  Article CAS PubMed Google Scholar
• Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J. F. & Young, L. T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260–265 (2001).
  Article CAS PubMed Google Scholar
• Cotman, C. W. & Berchtold, N. C. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 25, 295–301 (2002).
  Article CAS PubMed Google Scholar
• Neeper, S. A., Gomez-Pinilla, F., Choi, J. & Cotman, C. W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 726, 49–56 (1996).
  Article CAS PubMed Google Scholar
• Fuss, J. et al. Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus 20, 364–376 (2010).
  PubMed Google Scholar
• Shimizu, E., Hashimoto, K. & Iyo, M. Ethnic difference of the BDNF 196G/A (val166met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am. J. Med. Genet. B Neuropsychiatr. Genet. 126B, 122–123 (2004).
  Article PubMed Google Scholar
• Dempster, E. et al. Association between BDNF val66 met genotype and episodic memory. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B, 73–75 (2005).
  Article PubMed Google Scholar
• Hariri, A. R. et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23, 6690–6694 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Pezawas, L. et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 24, 10099–10102 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Erickson, K. I. et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J. Neurosci. 30, 5368–5375 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rybakowski, J. K. BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 9, 1589–1593 (2008).
  Article CAS PubMed Google Scholar
• Sugiyama, N., Kanba, S. & Arita, J. Temporal changes in the expression of brain-derived neurotrophic factor mRNA in the ventromedial nucleus of the hypothalamus of the developing rat brain. Brain Res. Mol. Brain Res. 115, 69–77 (2003).
  Article CAS PubMed Google Scholar
• Pelleymounter, M. A., Cullen, M. J. & Wellman, C. L. Characteristics of BDNF-induced weight loss. Exp. Neurol. 131, 229–238 (1995).
  Article CAS PubMed Google Scholar
• Fox, E. A. & Byerly, M. S. A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R994–R1004 (2004).
  Article CAS PubMed Google Scholar
• Rios, M. et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15, 1748–1757 (2001).
  Article CAS PubMed Google Scholar
• Gray, J. et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55, 3366–3371 (2006).
  Article CAS PubMed Google Scholar
• Yeo, G. S. et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neurosci. 7, 1187–1189 (2004).
  Article CAS PubMed Google Scholar
• Tonra, J. R. et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Leprdb/leprdb mice. Diabetes 48, 588–594 (1999).
  Article CAS PubMed Google Scholar
• Ono, M. et al. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism 49, 129–133 (2000).
  Article CAS PubMed Google Scholar
• Fujinami, A. et al. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance. Clin. Biochem. 41, 812–817 (2008).
  Article CAS PubMed Google Scholar
• Winkler, J. et al. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann. Neurol. 41, 82–93 (1997).
  Article CAS PubMed Google Scholar
• Williams, L. R. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp. Neurol. 113, 31–37 (1991).
  Article CAS PubMed Google Scholar
• Eriksdotter Jonhagen, M. et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9, 246–257 (1998).
  Article CAS PubMed Google Scholar
• Isaacson, L. G., Saffran, B. N. & Crutcher, K. A. Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels. Neurobiol. Aging 11, 51–55 (1990).
  Article CAS PubMed Google Scholar
• Nutt, J. G. et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60, 69–73 (2003).
  Article CAS PubMed Google Scholar
• Lang, A. E. et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59, 459–466 (2006).
  Article CAS PubMed Google Scholar
• Hovland, D. N. Jr et al. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys. Toxicol. Pathol. 35, 1013–1029 (2007).
  Article CAS PubMed Google Scholar
• Gasmi, M. et al. Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease. Mol. Ther. 15, 62–68 (2007).
  Article CAS PubMed Google Scholar
• Christine, C. W. et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 73, 1662–1669 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Feigin, A. et al. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc. Natl Acad. Sci. USA 104, 19559–19564 (2007).
  Article PubMed PubMed Central Google Scholar
• Marks, W. J. Jr et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 7, 400–408 (2008). This article reported the results of gene delivery of the growth factor neurturin in a clinical trial of Parkinson's disease.
  Article PubMed Google Scholar
• Worgall, S. et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum. Gene Ther. 19, 463–474 (2008).
  Article CAS PubMed Google Scholar
• Marks, W. J. Jr et al. Gene delivery of AAV2–neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 9, 1164–1172 (2010).
  Article CAS PubMed Google Scholar
• Herzog, C. D. et al. Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease. Neurosurgery 64, 602–613 (2009).
  Article PubMed Google Scholar
• Fiandaca, M. S. et al. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage 47 (Suppl. 2), 27–35 (2009).
  Article Google Scholar
• Martinowich, K. et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890–893 (2003).
  Article CAS PubMed Google Scholar
• Roth, T. L., Lubin, F. D., Funk, A. J. & Sweatt, J. D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol. Psychiatry 65, 760–769 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lubin, F. D., Roth, T. L. & Sweatt, J. D. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J. Neurosci. 28, 10576–10586 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ma, D. K. et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323, 1074–1077 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tsankova, N. M. et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neurosci. 9, 519–525 (2006).
  Article CAS PubMed Google Scholar
• Young, W. Review of lithium effects on brain and blood. 18, 951–975 Cell Transplant. (2009).
  Article PubMed Google Scholar
• Drzyzga, L. R., Marcinowska, A. & Obuchowicz, E. Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies. Brain Res. Bull. 79, 248–257 (2009).
  Article CAS PubMed Google Scholar
• Quiroz, J. A., Machado-Vieira, R., Zarate, C. A. Jr & Manji, H. K. Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62, 50–60 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Leyhe, T. et al. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. J. Alzheimers Dis. 16, 649–656 (2009).
  Article CAS PubMed Google Scholar
• Adessi, C. & Soto, C. Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr. Med. Chem. 9, 963–978 (2002).
  Article CAS PubMed Google Scholar
• O'Leary, P. D. & Hughes, R. A. Design of potent peptide mimetics of brain-derived neurotrophic factor. J. Biol. Chem. 278, 25738–25744 (2003).
  Article CAS PubMed Google Scholar
• Longo, F. M. et al. Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms. Curr. Alzheimer Res. 4, 503–506 (2007).
  Article CAS PubMed Google Scholar
• Price, R. D., Milne, S. A., Sharkey, J. & Matsuoka, N. Advances in small molecules promoting neurotrophic function. Pharmacol. Ther. 115, 292–306 (2007).
  Article CAS PubMed Google Scholar
• Vaynman, S., Ying, Z. & Gomez-Pinilla, F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur. J. Neurosci. 20, 2580–2590 (2004).
  Article PubMed Google Scholar
• Lee, J., Duan, W., Long, J. M., Ingram, D. K. & Mattson, M. P. Dietary restriction increases the number of newly generated neural cells, and induces BDNF expression, in the dentate gyrus of rats. J. Mol. Neurosci. 15, 99–108 (2000).
  Article CAS PubMed Google Scholar
• Molteni, R., Barnard, R. J., Ying, Z., Roberts, C. K. & Gomez-Pinilla, F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 112, 803–814 (2002).
  Article CAS PubMed Google Scholar
• Maswood, N. et al. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc. Natl Acad. Sci. USA 101, 18171–18176 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Duan, W. & Mattson, M. P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57, 195–206 (1999).
  Article CAS PubMed Google Scholar
• Duan, W., Guo, Z., Jiang, H., Ware, M. & Mattson, M. P. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 144, 2446–2453 (2003).
  Article CAS PubMed Google Scholar
• Pang, T. Y., Stam, N. C., Nithianantharajah, J., Howard, M. L. & Hannan, A. J. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 141, 569–584 (2006).
  Article CAS PubMed Google Scholar
• Nichol, K., Deeny, S. P., Seif, J., Camaclang, K. & Cotman, C. W. Exercise improves cognition and hippocampal plasticity in APOE ɛ4 mice. Alzheimers Dement. 5, 287–294 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Goverdhana, S. et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol. Ther. 12, 189–211 (2005).
  Article CAS PubMed Google Scholar
• Su, X. et al. Real-time MR imaging with gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors. Mol. Ther. 18, 1490–1495 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Massa, S. M. et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J. Clin. Invest. 120, 1774–1785 (2010). A recent study that revealed the potential effects of small peptide mimetics of BDNF in neurodegenerative disease models.
  Article CAS PubMed PubMed Central Google Scholar
• Yan, Q. et al. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J. Comp. Neurol. 378, 135–157 (1997).
  Article CAS PubMed Google Scholar
• Lu, B., Buck, C. R., Dreyfus, C. F. & Black, I. B. Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF. Exp. Neurol. 104, 191–199 (1989).
  Article CAS PubMed Google Scholar
• Koshimizu, H., Hazama, S., Hara, T., Ogura, A. & Kojima, M. Distinct signaling pathways of precursor BDNF and mature BDNF in cultured cerebellar granule neurons. Neurosci. Lett. 473, 229–232 (2010).
  Article CAS PubMed Google Scholar
• Armanini, M. P., McMahon, S. B., Sutherland, J., Shelton, D. L. & Phillips, H. S. Truncated and catalytic isoforms of trkB are co-expressed in neurons of rat and mouse CNS. Eur. J. Neurosci. 7, 1403–1409 (1995).
  Article CAS PubMed Google Scholar
• Ohira, K. et al. Truncated TrkB-T1 regulates the morphology of neocortical layer I astrocytes in adult rat brain slices. Eur. J. Neurosci. 25, 406–416 (2007).
  Article PubMed Google Scholar
• Huang, E. J. & Reichardt, L. F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609–642 (2003).
  Article CAS PubMed Google Scholar
• Zheng, J. et al. Clathrin-dependent endocytosis is required for TrkB-dependent Akt-mediated neuronal protection and dendritic growth. J. Biol. Chem. 283, 13280–13288 (2008).
  Article CAS PubMed Google Scholar
• Howe, C. L., Valletta, J. S., Rusnak, A. S. & Mobley, W. C. NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras–MAPK pathway. Neuron 32, 801–814 (2001).
  Article CAS PubMed Google Scholar
• Sharma, N. et al. Long-distance control of synapse assembly by target-derived NGF. Neuron 67, 422–434 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kafitz, K. W., Rose, C. R., Thoenen, H. & Konnerth, A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 401, 918–921 (1999).
  Article CAS PubMed Google Scholar
• Blum, R., Kafitz, K. W. & Konnerth, A. Neurotrophin-evoked depolarization requires the sodium channel NaV1.9. Nature 419, 687–693 (2002).
  Article CAS PubMed Google Scholar
• Tuszynski, M. H. Growth factor gene delivery: animal models to clinical trials. Dev. Neurobiol. 67, 1204–1215 (2007).
  Article CAS PubMed Google Scholar
• Hadaczek, P. et al. Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2–hAADC. Mol. Ther. 18, 1458–1461 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Forsayeth, J. R. et al. A dose-ranging study of AAV–hAADC therapy in Parkinsonian monkeys. Mol. Ther. 14, 571–577 (2006).
  Article CAS PubMed Google Scholar
• Sanftner, L. M. et al. AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters. Exp. Neurol. 194, 476–483 (2005).
  Article CAS PubMed Google Scholar
• Tenenbaum, L. et al. Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene Med. 6 (Suppl. 1), 212–222 (2004).
  Article CAS Google Scholar
• Graham, L. D. Ecdysone-controlled expression of transgenes. Expert Opin. Biol. Ther. 2, 525–535 (2002).
  Article CAS PubMed Google Scholar
• Blesch, A. et al. Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons. Mol. Ther. 11, 916–925 (2005).
  Article CAS PubMed Google Scholar